Почетна › Кронова болест › Тексас
Kliničke studije za Кронова болест u državi Тексас
34 studija za Кронова болест traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
- Houston17 студија
- Tyler16 студија
- San Antonio14 студија
- Lubbock9 студија
- Lewisville8 студија
- Dallas8 студија
- Round Rock6 студија
- The Woodlands6 студија
- Fort Worth6 студија
- League City4 студија
- Garland4 студија
- Austin3 студија
- Arlington3 студија
Zvanični tekst studije (na engleskom)
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04751396Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- и још 3
Тражи се учесникФаза 3
Сви узрасти · Оба пола · Ажурирано 10. 11. 2026. · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Baylor University Medical Center ( Site 5031), Dallas
- Epic Medical Research - Mesquite ( Site 5153), Denton
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- и још 5
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483073Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- GI Alliance - Cedar Park, Cedar Park
- North Texas Gastroenterology, Denton
- The University of Texas Health Science Center at Houston, Houston
- и још 3
Тражи се учесникФаза 2
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT06226883A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483099A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- The University of Texas at Austin, Austin
- DFW Clinical Trials, Carrollton
- Baylor University Medical Center, Dallas
- и још 5
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07196722A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Tyler Research Institute, LLC, Tyler
- GIA Webster, Webster
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07577843A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
Тражи се учесникФаза 3
Узраст 3 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06663332A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cook Childrens Medical Center, Fort Worth
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT05923073A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- DFW Clinical Trials, Carrollton
- Lubbock Gastroenterology, Lubbock
- Gastroenterology Research of America, LLC, San Antonio
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07499232A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT04372108A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Novel Research, LLC, Bellaire
- One of a Kind Clinical research Center TX LLC, Kingwood
- Southern Star Research Institute, LLC, San Antonio
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT06233461A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400002, Fredericksburg
- Investigational Site Number: 8400010, Houston
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT06958536A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- и још 7
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- GI Alliance -Garland /ID# 284253, Garland
- и још 10
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
- SMS Clinical Research-Site Number: 8400035, Mesquite
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
- и још 2
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184944An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Inquest Clinical Research-Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center-Site Number: 8400098, Dallas
- Valley Institute of Research-Site Number: 8400004, Harlingen
- и још 8
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
Тражи се учесникФаза 3
Узраст од 2 до 19 · Оба пола · Ажурирано 7. 10. 2026. · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cook Children's Medical Center, Fort Worth
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 7. 10. 2026. · NCT05509777Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gi Alliance - Cedar Park /ID# 268153, Cedar Park
- Houston Methodist Hospital /ID# 265533, Houston
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
- и још 3
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542Standardized Microbiota Transplant Therapy in Crohn's Disease
- UT Southwestern, Dallas
Тражи се учесникФаза 2
Узраст од 18 до 89 · Оба пола · Ажурирано 8. 9. 2026. · NCT06631586Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT05230173HB-adMSCs for the Treatment of Crohn's Disease
- Hope Biosciences Research Foundation, Sugar Land
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 6. 8. 2026. · NCT07077746A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 27. 5. 2026. · NCT06227910A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 22. 5. 2026. · NCT06764615A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
Тражи се учесникФаза 3
Узраст 2 и старији · Оба пола · Ажурирано 7. 5. 2026. · NCT05442567A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Texas Children's Hospital, Houston
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 5. 5. 2026. · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Central Texas Clinical Research, LLC, Austin
- Inquest Clinical Research, Baytown
- Novel Research, LLC, Bellaire
- и још 8
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 4. 2026. · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- и још 5
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 3. 2026. · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Houston Methodist Hospital, Houston
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 15. 1. 2026. · NCT06257706Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
Тражи се учесникОпсервациона студија
Узраст од 18 до 100 · Оба пола · Ажурирано 18. 5. 2021. · NCT04617184Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.